An organic NIR-II nanofluorophore with aggregation-induced emission characteristics for in vivo fluorescence imaging

Wei Wu,1,* Yan-Qing Yang,2,* Yang Yang,1,* Yu-Ming Yang,2 Hong Wang,2 Kai-Yuan Zhang,1 Li Guo,3 Hong-Fei Ge,1 Jie Liu,2 Hua Feng11Department of Neurosurgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, People’s Republic of China; 2Key...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wu W, Yang YQ, Yang Y, Yang YM, Wang H, Zhang KY, Guo L, Ge HF, Liu J, Feng H
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/5080c55b28234fe29e46594690f61faa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5080c55b28234fe29e46594690f61faa
record_format dspace
spelling oai:doaj.org-article:5080c55b28234fe29e46594690f61faa2021-12-02T08:14:19ZAn organic NIR-II nanofluorophore with aggregation-induced emission characteristics for in vivo fluorescence imaging1178-2013https://doaj.org/article/5080c55b28234fe29e46594690f61faa2019-05-01T00:00:00Zhttps://www.dovepress.com/an-organic-nir-ii-nanofluorophore-with-aggregation-induced-emission-ch-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Wei Wu,1,* Yan-Qing Yang,2,* Yang Yang,1,* Yu-Ming Yang,2 Hong Wang,2 Kai-Yuan Zhang,1 Li Guo,3 Hong-Fei Ge,1 Jie Liu,2 Hua Feng11Department of Neurosurgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, People’s Republic of China; 2Key Laboratory of Flexible Electronics (KLOFE) Institute of Advanced Materials (IAM), Nanjing Tech University, Nanjing 211800, People’s Republic of China; 3Department of Endocrinology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, People’s Republic of China*These authors contributed equally to this workBackground: In vivo fluorescence imaging in the second near-infrared (NIR-II, 1000–1700 nm) window using organic fluorophores has great advantages, but generally suffers from a relatively low fluorescence quantum yield (mostly less than 2%). In this study, organic nanoparticles (L1013 NPs) with a high fluorescence quantum yield (9.9%) were systhesized for in vivo imaging.Methods: A molecule (BTPPA) with donor-acceptor-donor structure and aggregation-induced emission enabling moieties was prepared. BTPPA molecules were then encapsulated into nanoparticles (L1013 NPs) using a nanoprecipitation method. The L1013 NPs were intravenously injected into the mice (including normal, stroke and tumor models) for vascular and tumor imaging.Results: L1013 NPs excited at 808 nm exhibit NIR-II emission with a peak at 1013 nm and an emission tail extending to 1400 nm. They have a quantum yield of 9.9% and also show excellent photo/colloidal stabilities and negligible in vitro and in vivo toxicity. We use L1013 NPs for noninvasive real-time visualization of mouse hindlimb and cerebral vessels (including stroke pathology) under a very low power density (4.6–40 mW cm‒2) and short exposure time (40–100 ms). Moreover, L1013 NPs are able to localize tumor pathology, with a tumor-to-normal tissue ratio of 11.7±1.3, which is unusually high for NIR-II fluorescent imaging through passive targeting strategy.Conclusion: L1013 NPs demonstrate the potential for a range of clinical applications, especially for tumor surgery.Keywords: fluorescence NIR-II imaging, aggregation-induced emission, organic nanoparticle, vascular imaging, tumor imagingWu WYang YQYang YYang YMWang HZhang KYGuo LGe HFLiu JFeng HDove Medical Pressarticlefluorescence NIR-II imagingaggregation-induced emissionorganic nanoparticlevascular imagingtumor imagingMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 3571-3582 (2019)
institution DOAJ
collection DOAJ
language EN
topic fluorescence NIR-II imaging
aggregation-induced emission
organic nanoparticle
vascular imaging
tumor imaging
Medicine (General)
R5-920
spellingShingle fluorescence NIR-II imaging
aggregation-induced emission
organic nanoparticle
vascular imaging
tumor imaging
Medicine (General)
R5-920
Wu W
Yang YQ
Yang Y
Yang YM
Wang H
Zhang KY
Guo L
Ge HF
Liu J
Feng H
An organic NIR-II nanofluorophore with aggregation-induced emission characteristics for in vivo fluorescence imaging
description Wei Wu,1,* Yan-Qing Yang,2,* Yang Yang,1,* Yu-Ming Yang,2 Hong Wang,2 Kai-Yuan Zhang,1 Li Guo,3 Hong-Fei Ge,1 Jie Liu,2 Hua Feng11Department of Neurosurgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, People’s Republic of China; 2Key Laboratory of Flexible Electronics (KLOFE) Institute of Advanced Materials (IAM), Nanjing Tech University, Nanjing 211800, People’s Republic of China; 3Department of Endocrinology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, People’s Republic of China*These authors contributed equally to this workBackground: In vivo fluorescence imaging in the second near-infrared (NIR-II, 1000–1700 nm) window using organic fluorophores has great advantages, but generally suffers from a relatively low fluorescence quantum yield (mostly less than 2%). In this study, organic nanoparticles (L1013 NPs) with a high fluorescence quantum yield (9.9%) were systhesized for in vivo imaging.Methods: A molecule (BTPPA) with donor-acceptor-donor structure and aggregation-induced emission enabling moieties was prepared. BTPPA molecules were then encapsulated into nanoparticles (L1013 NPs) using a nanoprecipitation method. The L1013 NPs were intravenously injected into the mice (including normal, stroke and tumor models) for vascular and tumor imaging.Results: L1013 NPs excited at 808 nm exhibit NIR-II emission with a peak at 1013 nm and an emission tail extending to 1400 nm. They have a quantum yield of 9.9% and also show excellent photo/colloidal stabilities and negligible in vitro and in vivo toxicity. We use L1013 NPs for noninvasive real-time visualization of mouse hindlimb and cerebral vessels (including stroke pathology) under a very low power density (4.6–40 mW cm‒2) and short exposure time (40–100 ms). Moreover, L1013 NPs are able to localize tumor pathology, with a tumor-to-normal tissue ratio of 11.7±1.3, which is unusually high for NIR-II fluorescent imaging through passive targeting strategy.Conclusion: L1013 NPs demonstrate the potential for a range of clinical applications, especially for tumor surgery.Keywords: fluorescence NIR-II imaging, aggregation-induced emission, organic nanoparticle, vascular imaging, tumor imaging
format article
author Wu W
Yang YQ
Yang Y
Yang YM
Wang H
Zhang KY
Guo L
Ge HF
Liu J
Feng H
author_facet Wu W
Yang YQ
Yang Y
Yang YM
Wang H
Zhang KY
Guo L
Ge HF
Liu J
Feng H
author_sort Wu W
title An organic NIR-II nanofluorophore with aggregation-induced emission characteristics for in vivo fluorescence imaging
title_short An organic NIR-II nanofluorophore with aggregation-induced emission characteristics for in vivo fluorescence imaging
title_full An organic NIR-II nanofluorophore with aggregation-induced emission characteristics for in vivo fluorescence imaging
title_fullStr An organic NIR-II nanofluorophore with aggregation-induced emission characteristics for in vivo fluorescence imaging
title_full_unstemmed An organic NIR-II nanofluorophore with aggregation-induced emission characteristics for in vivo fluorescence imaging
title_sort organic nir-ii nanofluorophore with aggregation-induced emission characteristics for in vivo fluorescence imaging
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/5080c55b28234fe29e46594690f61faa
work_keys_str_mv AT wuw anorganicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT yangyq anorganicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT yangy anorganicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT yangym anorganicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT wangh anorganicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT zhangky anorganicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT guol anorganicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT gehf anorganicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT liuj anorganicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT fengh anorganicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT wuw organicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT yangyq organicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT yangy organicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT yangym organicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT wangh organicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT zhangky organicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT guol organicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT gehf organicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT liuj organicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
AT fengh organicniriinanofluorophorewithaggregationinducedemissioncharacteristicsforinvivofluorescenceimaging
_version_ 1718398599042170880